Applications of large language models in tumor boards: a systematic review
Oncology Reviews · 20.05.2026 · 20
DOI: 10.3389/or.2026.1757059 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Oncology Reviews, online erschienen am 20.05.2026. Verfasst von Benjamin Konzmann und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Urology, University Hospital Basel, Basel, Switzerland. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Multidisciplinary tumor boards (MDTs) are the gold standard for cancer care but currently face significant pressure from rising case volumes and the increasing complexity of precision medicine. Large Language Models (LLMs) offer potential as Clinical Decision Support Systems (CDSS) to augment these workflows. This systematic review evaluates the current applications, accuracy, and safety of LLMs in MDT decision-making.
Methods
A systematic review was conducted following PRISMA 2020 guidelines. We searched PubMed/MEDLINE, Embase, IEEE Xplore, and arXiv for primary research published between January 2023 and November 2025. Inclusion criteria required studies to evaluate LLM performance in tumor board settings against human consensus or established clinical guidelines.
Results
Thirty-one studies encompassing 3,845 unique patient cases were included. The analysis revealed a distinct “complexity gap” in model performance. In standardized, high-incidence domains such as breast and prostate cancer, advanced models (particularly the GPT-4 family) demonstrated high concordance (up to 94%) with human experts. However, performance degraded significantly in complex, rare, or multimodal scenarios—such as sarcoma or neuro-oncology—where models struggled with “gray zone” decision-making and lacked the ability to interpret non-textual data. While LLMs showed utility in administrative tasks and guideline retrieval, they remained prone to hallucinations and lacked the nuance required for holistic patient assessment.
Conclusion
Current LLMs exhibit sufficient maturity to function as assistive tools for documentation and decision support in routine oncological cases but are not yet reliable enough for autonomous decision-making. Successful clinical implementation will require “human-in-the-loop” safeguards, the development of multimodal architectures, and rigorous prospective validation to ensure patient safety.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Urology, University Hospital Basel, Basel, Switzerland.
- Digitalisation and ICT, University Hospital Basel, Basel, Switzerland.
- Institute of Radiology, University Hospital Basel, Basel, Switzerland.
Zitieren
APA
Konzmann, B., Henkel, M., Breit, C., & Wetterauer, C. (2026). Applications of large language models in tumor boards: a systematic review. Oncology Reviews, 20. https://doi.org/10.3389/or.2026.1757059
Vancouver
Konzmann B, Henkel M, Breit C, Wetterauer C. Applications of large language models in tumor boards: a systematic review. Oncology Reviews. 2026;20. doi:10.3389/or.2026.1757059
BibTeX
@article{Konzmann2026,
author = {Konzmann, Benjamin and Henkel, Maurice and Breit, Christian and Wetterauer, Christian},
title = {Applications of large language models in tumor boards: a systematic review},
journal = {Oncology Reviews},
year = {2026},
volume = {20},
doi = {10.3389/or.2026.1757059}
}
EUVIMED